ethoxzolamide has been researched along with Cancer of Endocrine Gland in 1 studies
Ethoxzolamide: A carbonic anhydrase inhibitor used as diuretic and in glaucoma. It may cause hypokalemia.
ethoxzolamide : A sulfonamide that is 1,3-benzothiazole-2-sulfonamide which is substituted by an ethoxy group at position 6. A carbonic anhydrase inhibitor, it has been used in the treatment of glaucoma, and as a diuretic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lankat-Buttgereit, B | 1 |
| Gregel, C | 1 |
| Knolle, A | 1 |
| Hasilik, A | 1 |
| Arnold, R | 1 |
| Göke, R | 1 |
1 other study available for ethoxzolamide and Cancer of Endocrine Gland
| Article | Year |
|---|---|
Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II.
Topics: Animals; Apoptosis Regulatory Proteins; Carbonic Anhydrase II; Cell Division; Cell Line, Tumor; Clon | 2004 |